M K Hoseini-Asl1, B Amra. 1. Department of Medicine, Shahrekord University of Medical Sciences, PO Box 691, Shahrekord, Iran.
Abstract
BACKGROUND: As part of a public health program, we studied the prevalence of irritable bowel syndrome (IBS) as per the Rome II criteria, in Shahrekord community in Iran. METHODS: The study was conducted between August 2002 and March 2003. Of 5492 randomly selected subjects aged 20 years and above (from a total population of approximately 100,000), 4762 (86.7%) successfully completed interviews to fill in a questionnaire that looked into demographic data and various symptoms during the last one year. RESULTS: The 12-month prevalence of IBS was 5.8%. The female-to-male ratio among subjects with IBS was 1.17:1 and was similar to that among those without IBS. Pain relieved by defecation was reported by 427 (9%) subjects, pain associated with change in bowel habit by 340 (7.1%), and pain associated with change in the form of stool by 337 (7.1%) subjects. CONCLUSION: The prevalence of IBS in Shahrekord is lower than that reported from Western developed countries and is closer to that in Asian populations.
BACKGROUND: As part of a public health program, we studied the prevalence of irritable bowel syndrome (IBS) as per the Rome II criteria, in Shahrekord community in Iran. METHODS: The study was conducted between August 2002 and March 2003. Of 5492 randomly selected subjects aged 20 years and above (from a total population of approximately 100,000), 4762 (86.7%) successfully completed interviews to fill in a questionnaire that looked into demographic data and various symptoms during the last one year. RESULTS: The 12-month prevalence of IBS was 5.8%. The female-to-male ratio among subjects with IBS was 1.17:1 and was similar to that among those without IBS. Pain relieved by defecation was reported by 427 (9%) subjects, pain associated with change in bowel habit by 340 (7.1%), and pain associated with change in the form of stool by 337 (7.1%) subjects. CONCLUSION: The prevalence of IBS in Shahrekord is lower than that reported from Western developed countries and is closer to that in Asian populations.
Authors: R Spiller; Q Aziz; F Creed; A Emmanuel; L Houghton; P Hungin; R Jones; D Kumar; G Rubin; N Trudgill; P Whorwell Journal: Gut Date: 2007-05-08 Impact factor: 23.059